Fresenius Medical Care reported adjusted net income for the first quarter of 2017 grew 17% to 249 million euros (approximately $271 million US). Net income including the agreement with the U.S. Departments of Veterans Affairs was 308 million euros, an increase of 45%.
North America revenue, which represents 74% of the company’s total revenue, increased 18% to
3.375 million euros, attributable to higher reimbursement rates from commercial payers, an increase in treatments, and lower costs for health care supplies. At constant currency rates growth was at 14%.
“While both our dialysis services and products business showed strong growth, our care coordination activities confirmed its high growth potential,” said CEO Rice Powell. “We are shaping our activities in this area and expect the profitability to improve in the course of the year. We are clearly on track to deliver on our ambitious targets for 2017.”
The North American dialysis business grew 14% (10% at constant currency) and care coordination increased 39% (34% at constant currency).
Asia-Pacific revenue grew 11% (7% at constant currency) to 378 million euros.